Avoid common mistakes on your manuscript.
Erratum to: Cardiovasc Drugs Ther
DOI 10.1007/s10557-011-6298-4
In the reference list the first reference should be the more recent reference ‘Japanese Circulation Society. Guidelines for the diagnosis and treatment of cardiovascular disease (Joint Study Group Report 2009): guidelines for treatment of chronic heart failure (revised 2010). http://www.j-circ.or.jp/guideline/pdf/JCS2010_matsuzaki_h.pdf. Accessed 13 April 2011.
Following this change, the increase in body weight on page 1 should read ‘2-3 kg’ not ‘2-5 kg’. Also, the guidelines should be referred to in the text as ‘Guidelines for Treatment of Chronic Heart Failure (revised 2010).’
In addition, the full meaning of SIADH is ‘Syndrome of inappropriate secretion of antidiuretic hormone’ not ‘Syndrome of inappropriate antidiuretic hormone secretion’.
On page 3, the phase 1 study should be cited as reference [10] not reference [13].
Finally, the full citations for references 10, 11, 12, 13, 14, 15, 16 and 17 should be ‘e-pub ahead of print’ not ‘submitted’
Author information
Authors and Affiliations
Corresponding author
Additional information
The online version of the original article can be found at http://dx.doi.org/10.1007/s10557-011-6298-4.
Rights and permissions
About this article
Cite this article
Hori, M. Erratum to: Tolvaptan for Heart Failure Patients with Volume Overload. Cardiovasc Drugs Ther 25 (Suppl 1), 101 (2011). https://doi.org/10.1007/s10557-011-6360-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10557-011-6360-2